Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Caroline Shamu

Harvard Medical School, Department: Biology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Merrimack Pharmaceuticals, Inc.

Disclosed Value
Listed Reason
Payment for services (e.g., consulting fees, honoraria, paid authorship)

A potential conflict arises from ongoing scientific collaborations with Merrimack scientists on:

• Drug-ligand responses in cancer cell lines including those from breast and other tissue

• Drug-ligand responses in non-transformed cell lines and some primary cells

• Study of some cell death receptors

• Collaboration on therapeutic antibodies from third parties

The Sorger laboratory, however, does not use or study Merrimack proprietary drugs and compounds.

Listed Research Project
Pharmaco Response Signatures and Disease Mechanism

Disease networks are complex interactions between multiple proteins. Precise understanding of the multifactorial perturbations imposed on multi-component networks is a crucial step in the development of a rational approach to drug discovery and personalization of therapy. The LINCS Center we propose will develop innovative computational and experimental methods for understanding cellular perturbagen-response networks and will make the resulting data and new knowledge accessible to the diverse community of molecular and computational biologists, medicinal chemists and clinical investigators through outreach.

Filed on October 03, 2014.

Tell us what you know about Caroline Shamu's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Caroline Shamu Harvard Medical School Conflict of Interest Merrimack Pharmaceuticals, Inc. $10,000 - $19,999
Caroline Shamu Harvard Medical School Conflict of Interest Merrimack Pharmaceuticals, Inc. $200,000 - $249,999
Caroline Shamu Harvard Medical School Conflict of Interest Merrimack Pharmaceuticals, Inc. $0 - $4,999
Caroline Shamu Harvard Medical School Conflict of Interest Merrimack Pharmaceuticals, Inc. $200,000 - $249,999
Caroline Shamu Harvard Medical School Conflict of Interest Merrimack Pharmaceuticals, Inc. $0 - $4,999
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page